Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cyr61 expression is associated with prognosis in patients with colorectal cancer.

Jeong D, Heo S, Sung Ahn T, Lee S, Park S, Kim H, Park D, Byung Bae S, Lee SS, Soo Lee M, Kim CJ, Jun Baek M.

BMC Cancer. 2014 Mar 7;14:164. doi: 10.1186/1471-2407-14-164.

2.

Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.

Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY, Shi XL, Koeffler HP, Tong XJ, Xie D.

PLoS One. 2007 Jun 20;2(6):e534.

3.
4.

Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.

Tang QL, Fan S, Li HG, Chen WL, Shen XM, Yuan XP, Chang SH, Song Y.

Oral Oncol. 2011 May;47(5):365-70. doi: 10.1016/j.oraloncology.2011.02.022.

PMID:
21439895
5.

CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S.

Mol Biol Rep. 2010 Jul;37(6):3029-36. doi: 10.1007/s11033-009-9873-z.

PMID:
19821051
6.

Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.

Liu W, Guan M, Su B, Ye C, Li J, Zhang X, Liu C, Li M, Lin Y, Lu Y.

Cancer Biol Ther. 2010 Jun 1;9(11):862-71.

PMID:
20364105
7.

Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.

Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE.

Endocr Relat Cancer. 2004 Dec;11(4):781-91.

8.

The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.

Jandova J, Beyer TE, Meuillet EJ, Watts GS.

Cell Biochem Funct. 2012 Dec;30(8):687-95. doi: 10.1002/cbf.2853.

9.

Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status.

Lv H, Fan E, Sun S, Ma X, Zhang X, Han DM, Cong YS.

J Cell Biochem. 2009 Mar 1;106(4):738-44. doi: 10.1002/jcb.22075.

PMID:
19180570
10.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

11.

Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.

Zhu XL, Liang L, Ding YQ.

Int J Colorectal Dis. 2008 Nov;23(11):1041-7. doi: 10.1007/s00384-008-0520-2.

PMID:
18665374
12.

Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S.

Biosci Rep. 2010 Dec;30(6):383-90. doi: 10.1042/BSR20090129.

PMID:
20001967
13.

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.

Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.

Clin Cancer Res. 2006 May 1;12(9):2795-803.

14.

ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.

Ma F, Bi L, Yang G, Zhang M, Liu C, Zhao Y, Wang Y, Wang J, Bai Y, Zhang Y.

Oncol Rep. 2014 Sep;32(3):1071-7. doi: 10.3892/or.2014.3313.

PMID:
25017610
15.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109.

PMID:
17698398
16.

Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer.

Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, Liu R, Huang W.

PLoS One. 2013 Apr 23;8(4):e61679. doi: 10.1371/journal.pone.0061679.

17.

Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases.

Harbaum L, Pollheimer MJ, Bauernhofer T, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, Langner C.

Mod Pathol. 2010 Jul;23(7):961-71. doi: 10.1038/modpathol.2010.83.

18.

Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.

Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.

Eur J Cancer. 2014 Apr;50(6):1207-21. doi: 10.1016/j.ejca.2013.12.010.

PMID:
24412052
19.

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E36-44. doi: 10.1002/mc.21993.

PMID:
24009195
20.

Expression of CTGF and Cyr61 in colorectal cancer.

Ladwa R, Pringle H, Kumar R, West K.

J Clin Pathol. 2011 Jan;64(1):58-64. doi: 10.1136/jcp.2010.082768.

PMID:
21081514
Items per page

Supplemental Content

Support Center